First New Brand Price Reductions
Page last updated: 1 February 2023
In accordance with Division 3A of Part VII of the National Health Act 1953 a first new brand statutory price reduction (FNB SPR) will apply when the first new brand (new brand) of a pharmaceutical item (trigger item) that is bioequivalent or biosimilar and has the same manner of administration (MoA) as an existing pharmaceutical item (existing item) is listed on the Pharmaceutical Benefits Scheme (PBS).
The criteria for a FNB SPR applies irrespective of the formulary status of the drug. When the FNB is listed for a drug that is in F1, the drug becomes multi-branded and moves from F1 to the F2 formulary. Some older drugs in F2 may also meet the criteria for a FNB SPR.
Application of FNB SPRs
Refer to the First New Brand Statutory Price Reduction Policy (PDF 381KB) - (Word 351KB) for details about the application of a FNB SPR, such as what percentage reduction will apply, including where the existing brand has an effective price, how the reductions are flowed-on to combination items and related brands, how to apply to list a first new brand on the PBS and obligations for first new brands such as guarantee of supply.
Ministerial Discretion
The Minister for Health can exercise discretion to not apply, or to reduce the magnitude of, an FNB SPR. For more information on the types of information and the matters that might be considered relevant to the exercise of Ministerial Discretion in relation to FNB SPR and the timeframes for making such an application, refer to the Ministerial Discretion web page.
History of FNB SPR reforms
As part of the PBS reforms in 2007, the 12.5% FNB price reduction policy that had operated as an administrative policy since 1 August 2005, was legislated. Through further reforms, the FNB SPR increased from 12.5% to 16% on 1 February 2011, then again from 16% to up to 25% on 1 October 2018.
From 1 July 2022, the National Health Amendment (Enhancing the Pharmaceutical Benefits Scheme) Act 2021 gives effect to the reforms in the Strategic Agreement with Medicines Australia and the Generic and Biosimilar Medicines Association. Amongst other things, the amendments to SPRs ensure that FNB SPRs automatically apply to existing pharmaceutical items, so new price agreements under section 85AD of the Act will not be required.
Historical FNB reductions
The below lists include the drugs and MoAs that have been subject to a statutory or administrative FNB reduction. The Department endeavours to update this list each time a new FNB SPR takes effect. New drugs and MoAs subject to a FNB SPR since the last update are in bold italics
- 1. Statutory 12.5%, 16% and 25% Reductions
- 2. Administrative 12.5% reductions
- 3. Partial 12.5% reductions
1. Statutory 12.5%, 16% and 25% Reductions
|
Drug |
Manner of Administration |
Date of Effect |
|---|---|---|
|
Abacavir with lamivudine |
Oral |
1 February 2018 |
|
Abacavir with Lamivudine (Applied to the lamivudine component) |
Oral |
1 August 2012 |
|
Abacavir with Lamivudine and Zidovudine (Applied to the lamivudine component) |
Oral |
1 August 2012 |
|
Abatacept |
Injection |
1 April 2017 |
|
Acamprosate |
Oral |
1 June 2018 |
|
Acarbose |
Oral |
1 June 2016 |
|
Aciclovir |
Application to the eye |
1 August 2021 |
|
Acitretin |
Oral |
1 April 2014 |
|
Adalimumab |
Injection |
1 April 2021 |
|
Adefovir |
Oral |
1 December 2014 |
|
Adrenaline |
Injection |
1 June 2018 |
|
Alendronic Acid |
Oral |
1 December 2007 |
|
Ambrisentan |
Oral |
1 December 2020 |
|
Amisulpride |
Oral |
1 August 2007 |
|
Amlodipine |
Oral |
1 August 2007 |
|
Amlodipine with Atorvastatin (amlodipine component)* |
Oral |
1 August 2007* |
|
Amlodipine with Valsartan |
Oral |
1 December 2012 |
|
Amlodipine with Valsartan and hydrochlorothiazide |
Oral |
1 December 2012 |
|
Anastrozole |
Oral |
1 April 2012 |
|
Apomorphine |
Injection |
1 February 2016 |
|
Aripiprazole |
Oral |
1 December 2016 |
|
Arsenic |
Injection |
1 December 2020 |
|
Aspirin |
Oral |
1 August 2012 |
|
Atazanavir |
Oral |
1 April 2019 |
|
Atazanavir with cobicistat (Applied to the atazanavir component) |
Oral |
1 April 2019 |
|
Atenolol |
Oral |
1 April 2011 |
|
Atomoxetine |
Oral |
1 August 2016 |
|
Atorvastatin |
Oral |
1 April 2012 |
|
Azacitidine |
Injection |
1 June 2016 |
|
Azithromycin |
Oral |
1 August 2009 |
|
Baclofen |
Injection |
1 April 2016 |
|
Bevacizumab |
Injection |
1 June 2021 |
|
Bicalutamide |
Oral |
1 August 2008 |
|
Bimatoprost |
Application to the eye |
1 October 2017 |
|
Bisoprolol |
Oral |
1 August 2009 |
|
Bivalirudin |
Injection |
1 December 2016 |
|
Bleomycin |
Injection |
1 April 2012 |
|
Bortezomib |
Injection |
1 June 2021 |
|
Bosentan |
Oral |
1 August 2017 |
|
Budesonide with eformoterol |
Inhalation by mouth |
1 April 2018 |
|
Buprenorphine |
Transdermal |
1 June 2018 |
|
Cabazitaxel |
Injection |
1 April 2021 |
|
Cabergoline |
Oral |
1 August 2009 |
|
Calcipotriol with betamethasone |
Application |
1 February 2017 |
|
Candesartan |
Oral |
1 April 2013 |
|
Candesartan with Hydrochlorothiazide (Applied to Candesartan component) |
Oral |
1 April 2013 |
|
Candesartan with Hydrochlorothiazide (Applied to Hydrochlorothiazide component) |
Oral |
1 August 2013 |
|
Capecitabine |
Oral |
1 August 2014 |
|
Carbimazole |
Oral |
1 February 2023 |
|
Carbomer |
Application to the eye |
1 April 2014 |
|
Carvedilol |
Oral |
1 April 2008 |
|
Cefepime |
Injection |
1 December 2010 |
|
Celecoxib |
Oral |
1 December 2014 |
|
Cephalothin/Cefalotin |
Injection |
1 August 2008 |
|
Cephazolin |
Injection |
1 December 2010 |
|
Certolizumab pegol |
Injection |
1 April 2018 |
|
Chorionic gonadotrophin |
Injection |
1 August 2017 |
|
Cinacalcet |
Oral |
1 April 2021 |
|
Clindamycin |
Oral |
1 December 2014 |
|
Clonidine |
Oral |
1 April 2017 |
|
Clopidogrel |
Oral |
1 April 2010 |
|
Clopidogrel with Aspirin |
Oral |
1 April 2010 |
|
Colchicine |
Oral |
1 August 2021 |
|
Cyproterone |
Oral |
1 August 2012 |
|
Darunavir |
Oral |
1 October 2021 |
|
Dasatinib |
Oral |
1 December 2021 |
|
Deferasirox |
Oral |
1 August 2021 |
|
Desvenlafaxine |
Oral |
1 April 2015 |
|
Dexamethasone |
Injection |
1 December 2011 |
|
Diazepam |
Oral |
1 August 2008 |
|
Dicloxacillin |
Oral |
1 June 2018 |
|
Diltiazem |
Oral |
1 August 2007 |
|
Dimethyl fumarate |
Oral |
1 February 2022 |
|
Dipyridamole with aspirin |
Oral |
1 December 2014 |
|
Domperidone |
Oral |
1 February 2023 |
|
Donepezil |
Oral |
1 April 2013 |
|
Dorzolamide |
Application to the eye |
1 April 2015 |
|
Dorzolamide with timolol |
Application to the eye |
1 December 2014 |
|
Doxorubicin - Pegylated Liposomal |
Injection |
1 April 2014 |
|
Duloxetine |
Oral |
1 April 2013 |
|
Dutasteride |
Oral |
1 December 2017 |
|
Dutasteride with tamsulosin |
Oral |
1 June 2020 |
|
Enalapril Maleate with Hydrochlorothiazide |
Oral |
1 April 2008 |
|
Enoxaparin |
Injection |
1 June 2018 |
|
Entecavir |
Oral |
1 December 2016 |
|
Epirubicin |
Injection/Intravesical |
1 April 2011 |
|
Eplerenone |
Oral |
1 June 2016 |
|
Epoprostenol |
Injection |
1 August 2014 |
|
Eprosartan |
Oral |
1 April 2013 |
|
Eprosartan with Hydrochlorothiazide (Applied to Eprosartan component) |
Oral |
1 April 2013 |
|
Erlotinib |
Oral |
1 April 2021 |
|
Etanercept |
Injection |
1 April 2017 |
|
Everolimus |
Oral |
1 June 2018 |
|
Exemestane |
Oral |
1 August 2011 |
|
Ezetimibe |
Oral |
1 June 2018 |
|
Ezetimibe and Rosuvastatin |
Oral |
1 June 2018 |
|
Ezetimibe with Simvastatin |
Oral |
1 June 2018 |
|
Felodipine |
Oral |
1 August 2007 |
|
Fenofibrate |
Oral |
1 June 2019 |
|
Fentanyl |
Transdermal |
1 August 2011 |
|
Filgrastim |
Injection |
1 April 2011 |
|
Fingolimod |
Oral |
1 December 2022 |
|
Flecainide |
Oral |
1 October 2016 |
|
Fluconazole |
Injection |
1 December 2007 |
|
Fludarabine |
Injection |
1 December 2008 |
|
Fludrocortisone |
Oral |
1 February 2022 |
|
Fluticasone |
Inhalation by mouth |
1 June 2017 |
|
Fluticasone with Salmeterol |
Inhalation by mouth |
1 June 2017 |
|
Follitropin Alfa |
Injection |
1 August 2016 |
|
Fosinopril with Hydrochlorothiazide |
Oral |
1 August 2007 |
|
Frusemide |
Oral |
1 April 2012 |
|
Fulvestrant |
Injection |
1 December 2021 |
|
Galantamine |
Oral |
1 August 2010 |
|
Ganciclovir |
Injection |
1 April 2018 |
|
Ganirelix |
Injection |
1 April 2021 |
|
Gefitinib |
Oral |
1 October 2020 |
|
Gemcitabine |
Injection |
1 April 2009 |
|
Gemfibrozil |
Oral |
1 April 2008 |
|
Glatiramer |
Injection |
1 February 2022 |
|
Glucose |
Injection |
1 August 2009 |
|
Hydromorphone |
Injection |
1 August 2019 |
|
Hydroxocobalamin |
Injection |
1 December 2010 |
|
Hydroxycarbamide |
Oral |
1 October 2020 |
|
Hydroxychloroquine |
Oral |
1 August 2012 |
|
Hyoscine |
Injection |
1 December 2017 |
|
Icatibant |
Injection |
1 October 2020 |
|
Ibuprofen |
Oral |
1 October 2017 |
|
Idarubicin |
Injection |
1 April 2011 |
|
Imatinib |
Oral |
1 October 2016 |
|
Imiquimod |
Application |
1 December 2012 |
|
Indapamide |
Oral |
1 August 2012 |
|
Infliximab |
Injection |
1 December 2015 |
|
Insulin glargine |
Injection |
1 October 2019 |
|
Interferon Beta-1b |
Injection |
1 April 2013 |
|
Irbesartan |
Oral |
1 April 2013 |
|
Irbesartan with Hydrochlorothiazide |
Oral |
1 April 2013 |
|
Isotretinoin |
Oral |
1 April 2011 |
|
Itraconazole |
Oral |
1 December 2016 |
|
Ivabradine |
Oral |
1 October 2018 |
|
Lacosamide |
Oral |
1 April 2022 |
|
Lamivudine |
Oral |
1 August 2012 |
|
Lamivudine with Zidovudine (Applied to the lamivudine component) |
Oral |
1 August 2012 |
|
Lamivudine with Zidovudine (Applied to the zidovudine component) |
Oral |
1 August 2013 |
|
Latanoprost |
Application to the eye |
1 August 2012 |
|
Latanoprost with Timolol |
Application to the eye |
1 August 2012 |
|
Leflunomide |
Oral |
1 August 2011 |
|
Lenalidomide |
Oral |
1 February 2023 |
|
Lercanidipine |
Oral |
1 August 2007 |
|
Letrozole |
Oral |
1 April 2012 |
|
Levodopa with carbidopa |
Oral |
1 April 2020 |
|
Levodopa with carbidopa and entacapone |
Oral |
1 August 2020 |
|
Levonorgestrel with Ethinylestradiol |
Oral |
1 April 2013 |
|
Levothyroxine |
Oral |
1 February 2022 |
|
Lincomycin |
Injection |
1 June 2018 |
|
Loperamide |
Oral |
1 December 2012 |
|
Losartan |
Oral |
1 April 2013 |
|
Lurasidone |
Oral |
1 August 2020 |
|
Macrogol 3350 |
Oral |
1 December 2010 |
|
Mefenamic acid |
Oral |
1 February 2022 |
|
Meloxicam |
Oral |
1 August 2007 |
|
Memantine |
Oral |
1 April 2010 |
|
Mercaptopurine |
Oral |
1 December 2020 |
|
Mesalazine |
Oral |
1 February 2022 |
|
Methenamine |
Oral |
1 February 2021 |
|
Methylprednisolone |
Injection |
1 August 2011 |
|
Metoclopramide |
Oral |
1 April 2014 |
|
Metoprolol succinate |
Oral |
1 August 2014 |
|
Metronidazole |
Injection |
1 April 2008 |
|
Misoprostol |
Oral |
1 August 2013 |
|
Modafinil |
Oral |
1 April 2016 |
|
Mometasone |
Application |
1 April 2013 |
|
Montelukast |
Oral |
1 August 2013 |
|
Morphine |
Injection |
1 August 2016 |
|
Morphine |
Oral |
1 August 2009 |
|
Moxonidine |
Oral |
1 June 2018 |
|
Mycophenolic Acid |
Oral |
1 April 2012 |
|
Naloxone |
Injection |
1 April 2017 |
|
Naltrexone |
Oral |
1 December 2007 |
|
Nebivolol |
Oral |
1 August 2018 |
|
Nevirapine |
Oral |
1 December 2012 |
|
Nicorandil |
Oral |
1 April 2015 |
|
Nifedipine |
Oral |
1 August 2007 |
|
Nitrofurantoin |
Oral |
1 August 2020 |
|
Nortriptyline |
Oral |
1 August 2017 |
|
Octreotide |
Injection |
1 December 2007 |
|
Olanzapine |
Oral |
1 April 2012 |
|
Olmesartan |
Oral |
1 April 2013 |
|
Olmesartan with Hydrochlorothiazide |
Oral |
1 April 2013* |
|
Olmesartan with Amlodipine (Applied to Olmersartan component ) |
Oral |
1 April 2013 |
|
Olmesartan with Amlodipine and Hydrochlorothiazide |
Oral |
1 April 2020 |
|
Omalizumab |
Injection |
1 August 2014 |
|
Omeprazole and Clarithromycin and Amoxycillin |
Oral |
1 December 2010 |
|
Oxazepam |
Oral |
1 August 2010 |
|
Oxybutynin |
Oral |
1 August 2007 |
|
Oxycodone |
Oral |
1 December 2014 |
|
Palonosetron |
Injection |
1 April 2022 |
|
Pegfilgrastim |
Injection |
1 April 2017 |
|
Perindopril with Indapamide |
Oral |
1 August 2007 |
|
Pioglitazone |
Oral |
1 April 2011 |
|
Plerixafor |
Injection |
1 October 2022 |
|
Polyethylene glycol 400 with proylene glycol |
Application to the eye |
1 February 2023 |
|
Pomalidomide |
Oral |
1 October 2022 |
|
Posaconazole |
Oral |
1 December 2020 |
|
Pramipexole |
Oral |
1 August 2012 |
|
Prazosin |
Oral |
1 April 2012 |
|
Pregabalin |
Oral |
1 August 2017 |
|
Prochlorperazine |
Oral |
1 August 2010 |
|
Propranolol |
Oral |
1 August 2015 |
|
Quetiapine |
Oral |
1 April 2012 |
|
Rasagiline |
Oral |
1 Feb 2019 |
|
Raloxifene |
Oral |
1 December 2014 |
|
Riluzole |
Oral |
1 December 2012 |
|
Risedronate Sodium |
Oral |
1 April 2011 |
|
Risedronate Sodium and Calcium Carbonate |
Oral |
1 April 2011 |
|
Risedronate Sodium and Calcium Carbonate with Colecalciferol |
Oral |
1 April 2011 |
|
Risperidone |
Oral |
1 December 2008 |
|
Rituximab |
Injection |
1 October 2019 |
|
Rivastigmine |
Transdermal |
1 December 2016 |
|
Rizatriptan |
Oral |
1 December 2015 |
|
Rosuvastatin |
Oral |
1 April 2012 |
|
Salbutamol |
Inhalation |
1 April 2008 |
|
Salbutamol |
Inhalation by mouth |
1 August 2011 |
|
Sevelamer |
Oral |
1 December 2019 |
|
Sildenafil |
Oral |
1 August 2014 |
|
Sitagliptin |
Oral |
1 August 2022 |
|
Sitagliptin with metformin |
Oral |
1 August 2022 |
|
Sodium Chloride |
Injection |
1 August 2009 |
|
Sodium Lactate Compound |
Injection |
1 August 2009 |
|
Somatropin |
Injection |
1 December 2015 |
|
Sorbitol with Sodium Citrate and Sodium Lauryl Sulfoacetate |
Rectal |
1 August 2010 |
|
Spironolactone |
Oral |
1 February 2021 |
|
Sunitinib |
Oral |
1 October 2021 |
|
Tacrolimus |
Oral |
1 December 2010 |
|
Tadalafil |
Oral |
1 October 2020 |
|
Telmisartan |
Oral |
1 April 2013 |
|
Telmisartan with Amlodipine (Applied to Telmarsartan component) |
Oral |
1 April 2013 |
|
Telmisartan with Hydrochlorothiazide (Applied to Telmisartan component) |
Oral |
1 April 2013 |
|
Telmisartan with Hydrochlorothiazide (Applied to hydrochlorothiazide component) |
Oral |
1 August 2013 |
|
Temazepam |
Oral |
1 August 2009 |
|
Temozolomide |
Oral |
1 December 2011 |
|
Tenofovir |
Oral |
1 August 2017 |
|
Tenofovir with emtricitabine |
Oral |
1 August 2017 |
|
Tenofovir with emtricitabine and efavirenz |
Oral |
1 August 2019 |
|
Teriflunomide |
Oral |
1 June 2019 |
|
Teriparatide |
Injection |
1 October 2021 |
|
Tetrabenazine |
Oral |
1 February 2023 |
|
Tiotropium |
Inhalation by mouth |
1 February 2020 |
|
Tirofiban |
Injection |
1 August 2014 |
|
Tobramycin |
Injection |
1 August 2016 |
|
Tocilizumab |
Injection |
1 December 2018 |
|
Topotecan |
Injection |
1 August 2012 |
|
Tranexamic acid |
Oral |
1 May 2017 |
|
Trastuzumab |
Injection |
1 August 2019 |
|
Ursodeoxycholic acid |
Oral |
1 April 2015 |
|
Valganciclovir |
Oral |
1 August 2017 |
|
Valproic Acid |
Oral |
1 August 2007 |
|
Valsartan |
Oral |
1 April 2013 |
|
Valsartan with Hydrochlorothiazide (Valsartan component)* |
Oral |
1 April 2013* |
|
Vancomycin |
Injection |
1 December 2007 |
|
Vancomycin |
Oral |
1 February 2023 |
|
Venlafaxine |
Oral |
1 April 2012 |
|
Voriconazole |
Oral |
1 February 2016 |
|
Ziprasidone |
Oral |
1 December 2013 |
|
Zoledronic Acid |
Injection |
1 December 2015 |
|
Zonisamide |
Oral |
1 June 2017 |
2. Administrative 12.5% reductions
|
Drug |
Manner of Administration |
Date of Effect |
|---|---|---|
|
Aciclovir |
Oral |
1 August 2006 |
|
Amitriptyline |
Oral |
1 August 2006 |
|
Amoxycillin |
Oral |
1 August 2006 |
|
Amoxycillin with Clavulanic Acid |
Oral |
1 August 2006 |
|
Bisacodyl |
Oral |
1 December 2005 |
|
Bupropion |
Oral |
1 April 2006 |
|
Calcitriol |
Oral |
1 August 2005 |
|
Calcium Folinate |
Injection |
1 April 2006 |
|
Captopril |
Oral |
1 August 2006 |
|
Carboplatin |
Injection |
1 December 2006 |
|
Cefaclor |
Oral |
1 August 2006 |
|
Cefotaxime |
Injection |
1 December 2006 |
|
Ceftriaxone |
Injection |
1 December 2006 |
|
Cefuroxime |
Oral |
1 August 2006 |
|
Cephalexin |
Oral |
1 August 2006 |
|
Cimetidine |
Oral |
1 August 2006 |
|
Ciprofloxacin |
Oral |
1 April 2006 |
|
Cisplatin |
Injection |
1 August 2006 |
|
Citalopram |
Oral |
1 August 2005 |
|
Clarithromycin |
Oral |
1 December 2005 |
|
Codeine with Paracetamol |
Oral |
1 August 2005 |
|
Cromoglycic Acid |
Application to the eye |
1 August 2006 |
|
Dexamphetamine |
Oral |
1 December 2005 |
|
Docetaxel |
Injection |
1 August 2005 |
|
Dolasetron |
Injection |
1 April 2006 |
|
Dolasetron |
Oral |
1 April 2006 |
|
Doxorubicin |
Injection/Intravesical |
1 August 2005 |
|
Electrolyte Replacement (Oral) |
Oral |
1 December 2005 |
|
Enalapril |
Oral |
1 August 2006 |
|
Erythromycin |
Oral |
1 December 2005 |
|
Escitalopram |
Oral |
1 August 2005 |
|
Esomeprazole |
Oral |
1 April 2006 |
|
Etidronic Acid and Calcium |
Oral |
1 August 2005 |
|
Etoposide |
Injection |
1 December 2005 |
|
Famciclovir |
Oral |
1 August 2006 |
|
Famotidine |
Oral |
1 August 2006 |
|
Fluconazole |
Oral |
1 December 2006 |
|
Fluorouracil |
Injection |
1 August 2006 |
|
Fluoxetine |
Oral |
1 August 2005 |
|
Fluvastatin |
Oral |
1 August 2005 |
|
Fluvoxamine |
Oral |
1 August 2005 |
|
Fosinopril |
Oral |
1 August 2006 |
|
Frusemide |
Injection |
1 December 2005 |
|
Gabapentin |
Oral |
1 August 2005 |
|
Gliclazide |
Oral |
1 April 2006 |
|
Glimepiride |
Oral |
1 April 2006 |
|
Granisetron |
Oral |
1 April 2006 |
|
Granisetron |
Injection |
1 April 2006 |
|
Imipramine |
Oral |
1 August 2006 |
|
Ipratropium |
Inhalation |
1 August 2005 |
|
Irinotecan |
Injection |
1 December 2006 |
|
Lansoprazole |
Oral |
1 April 2006 |
|
Lamotrigine |
Oral |
1 August 2005 |
|
Levetiracetam |
Oral |
1 August 2005 |
|
Lisinopril |
Oral |
1 August 2006 |
|
Metformin |
Oral |
1 December 2005 |
|
Methotrexate |
Injection |
1 December 2005 |
|
Methylphenidate |
Oral |
1 December 2005 |
|
Mirtazapine |
Oral |
1 August 2005 |
|
Mitozantrone |
Injection |
1 April 2006 |
|
Moclobemide |
Oral |
1 August 2005 |
|
Naratriptan |
Oral |
1 April 2007 |
|
Nizatidine |
Oral |
1 August 2006 |
|
Omeprazole |
Oral |
1 April 2006 |
|
Ondansetron |
Injection |
1 April 2006 |
|
Ondansetron |
Oral |
1 April 2006 |
|
Oxaliplatin |
Injection |
1 December 2006 |
|
Oxcarbazepine |
Oral |
1 August 2005 |
|
Paclitaxel |
Injection |
1 August 2005 |
|
Pantoprazole |
Oral |
1 April 2006 |
|
Paracetamol |
Oral |
1 December 2005 |
|
Paroxetine |
Oral |
1 August 2005 |
|
Pemetrexed |
Injection |
1 August 2005 |
|
Perindopril |
Oral |
1 August 2006 |
|
Pravastatin |
Oral |
1 August 2005 |
|
Quinapril |
Oral |
1 August 2006 |
|
Rabeprazole |
Oral |
1 April 2006 |
|
Ramipril |
Oral |
1 August 2006 |
|
Ranitidine |
Oral |
1 August 2006 |
|
Reboxetine |
Oral |
1 August 2005 |
|
Roxithromycin |
Oral |
1 December 2005 |
|
Sertraline |
Oral |
1 August 2005 |
|
Simvastatin |
Oral |
1 August 2005 |
|
Sumatriptan |
Oral |
1 April 2007 |
|
Terbinafine |
Oral |
1 December 2005 |
|
Tiagabine |
Oral |
1 August 2005 |
|
Topiramate |
Oral |
1 August 2005 |
|
Tramadol |
Injection |
1 August 2005 |
|
Tramadol |
Oral |
1 August 2005 |
|
Trandolapril |
Oral |
1 August 2006 |
|
Tropisetron |
Injection |
1 April 2006 |
|
Tropisetron |
Oral |
1 April 2006 |
|
Valaciclovir |
Oral |
1 August 2006 |
|
Vigabatrin |
Oral |
1 August 2005 |
|
Vinorelbine |
Injection |
1 August 2005 |
|
Zolmitriptan |
Oral |
1 April 2007 |
3. Partial 12.5% reductions
|
Drug |
Manner of Administration |
Details of Partial Reduction |
Date of Effect |
|---|---|---|---|
|
Doxorubicin, Pegylated Liposomal |
Injection |
3.5% (to account for use in ovarian cancer and Kaposi’s sarcoma) |
1 August 2005 |
|
Ezetimibe with Simvastatin |
Oral |
Applied to the simvastatin component |
1 August 2005 |
|
Metformin with Glibenclamide |
Oral |
Applied to the metformin component |
1 December 2005 |
|
Gemcitabine |
Injection |
6.1% to account for use in pancreatic and bladder cancer |
1 August 2005 |
|
Rosiglitazone with Metformin |
Oral |
Applied to the metformin component |
1 December 2005 |
|
Quinapril with Hydrochlorothiazide |
Oral |
Applied to the quinapril component |
1 August 2006 |
|
Trandolapril with Verapamil |
Oral |
Applied to the trandolapril component |
1 August 2006 |
|
Alendronic Acid with Colecalciferol |
Oral |
Applied to alendronic acid component |
1 December 2007 |
|
Goserelin Acetate and Bicalutamide |
Implantation/Oral |
Applied to bicalutamide component |
1 August 2008 |
